ADAPT-BLADDER study compares novel immunotherapy combinations and BCG re-treatment in non-muscle invasive bladder cancer
Hoosier Cancer Research Network (HCRN) has opened a study for patients with non-muscle invasive bladder cancer who were previously treated with the Bacillus Calmette-Guerin (BCG) […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter